Torainse Life Care Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.50 M
as on 11-12-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 M
as on 11-12-2024
- Revenue 28.20%
(FY 2022)
- Profit 81.29%
(FY 2022)
- Ebitda 77.16%
(FY 2022)
- Net Worth 20.91%
(FY 2022)
- Total Assets 1.25%
(FY 2022)
About Torainse Life Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.70 M.
Jasjeet Singh and Sarbinder Kaur serve as directors at the Company.
- CIN/LLPIN
U24100CH2014PTC035252
- Company No.
035252
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Torainse Life Care Private Limited offer?
Torainse Life Care Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Respiratory System Drugs, Anti Asthma Drug, Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Pharmaceutical Medicine, Pharmaceutical Syrup, PCD Pharma Franchise.
Who are the key members and board of directors at Torainse Life Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jasjeet Singh  | Director | 20-Oct-2014 | Current |
| Sarbinder Kaur | Director | 20-Oct-2014 | Current |
Financial Performance of Torainse Life Care.
Torainse Life Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.2% increase. The company also saw a substantial improvement in profitability, with a 81.29% increase in profit. The company's net worth Soared by an impressive increase of 20.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Torainse Life Care?
In 2022, Torainse Life Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Jan 2021 | ₹1.70 M | Open |
How Many Employees Work at Torainse Life Care?
Unlock and access historical data on people associated with Torainse Life Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Torainse Life Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Torainse Life Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
